Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCM) in a report released on Sunday. The firm issued a sell rating on the stock.

Concord Medical Services Stock Performance

NYSE CCM opened at $6.49 on Friday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.30 and a current ratio of 0.32. Concord Medical Services has a 1 year low of $3.82 and a 1 year high of $26.70. The company has a fifty day moving average of $6.67 and a two-hundred day moving average of $6.80.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.